Lancing Devices Market

Lancing device is an instrument equipped with a lancet. It is also most commonly used by diabetics during blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for fetal scalp blood testing to get a measure of the acid base status of the fetus.

The lancing device is a convenient medical tool for collecting capillary blood samples for glucose monitoring or other tests requiring one or two drops of blood. It is dedicated for home diagnostics and aimed to be used by patients when performing skin puncture on them. A convenient and effortless device specially designed for the highest comfort in daily diabetes management.

Lancing Devices Market contains market size and forecasts of Lancing Devices in global, including the following market information:

Global Lancing Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Lancing Devices Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Lancing Devices companies in 2021 (%)

The global Lancing Devices market was valued at 331.3 million in 2021 and is projected to reach US$ 450.8 million by 2028, at a CAGR of 4.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Adjustable Lancing Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lancing Devices include Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY and GMMC Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Lancing Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lancing Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lancing Devices Market Segment Percentages, by Type, 2021 (%)

Adjustable Lancing Device

Non-adjustable Lancing Device

Global Lancing Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lancing Devices Market Segment Percentages, by Application, 2021 (%)

Glucose Tests

Cholesterol Tests

Others

Global Lancing Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lancing Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lancing Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Lancing Devices revenues share in global market, 2021 (%)

Key companies Lancing Devices sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Lancing Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Lifescan

Abbott

Ascensia

B. Braun

TERUMO

Sinocare

ARKRAY

GMMC Group

BIONIME

LIANFA

Lobeck Medical AG